Almost one in two patients with ESRD dies as a result of cardiovascular disease. That is why Cardioprotective Haemodialysis is a core principle of Fresenius Medical Care, as we work and strive to solve the challenges of modern dialysis. Each step we take is focused on minimising cardiovascular risks and extending patients? lives. The 5008S CorDiax is the fundamental element achieving the essential benefits of cardioprotective haemodialysis whilst maintaining excellent usability and assuring the optimal use of dialysis-relevant resources. The 5008S CorDiax helps you to protect your patient - day by day. The highlights of the 5008S CorDiax are an innovative method for performing HighVolumeHDF® - AutoSubplus - and sophisticated safety features for venous access monitoring, allowing you to provide highly safe and effective treatment to your patients. The perfect fusion of easy handling and thoughtful use of dialysis relevant resources establishes the 5008S CorDiax as the standard device for haemodialysis treatment. The benefits of HighVolumeHDF® therapy are then just the push of a button away. The 5008S CorDiax is based on the three cornerstones: Best therapies Effective removal of middle molecular toxins Individual temperature control Defining and achieving the optimal dry weight Ensuring effective dialysis dose Highest level of patient safety Advanced therapies for home patients